Company news

NeoGenomics, Inc. news in 2023

NeoGenomics, Inc.'s news releases, calls and decks from 2023, newest first.

View company

NeoGenomics to Appeal Ruling

December 27, 2023

NeoGenomics to Present New Data at San Antonio Breast Cancer Symposium Highlighting Utility of RaDaR for Therapy Response

December 4, 2023

NeoGenomics to Participate at the Piper Sandler 35th Annual Healthcare Conference

November 13, 2023

NeoGenomics Reports Third Quarter 2023 Results

November 5, 2023

NeoGenomics Announces the Commercial Availability of Two New Tests, Expanding Its Next-Generation Sequencing and Lung Cancer Portfolios

October 23, 2023

NeoGenomics to Report Third Quarter 2023 Financial Results on November 6, 2023

October 16, 2023

NeoGenomics Reports Second Quarter 2023 Results

August 7, 2023

NeoGenomics Announces Medicare Coverage for RaDaR Assay for Minimal Residual Disease and Recurrence in Breast Cancer

July 26, 2023

NeoGenomics to Report Second Quarter 2023 Financial Results on August 8, 2023

July 17, 2023

NeoGenomics Expands Board of Directors with Appointments of Three Independent Directors

June 28, 2023

NeoGenomics' RaDaR Assay for Minimal Residual Disease Receives First Commercial Coverage

June 14, 2023

NeoGenomics and German Breast Group Announce New Data Demonstrating Clinical Potential of the RaDaR MRD Assay in HR+/HER2- Breast Cancer

June 4, 2023

NeoGenomics to Participate at the Goldman Sachs 44th Annual Global Healthcare Conference

May 31, 2023

NeoGenomics to Showcase the Transformational Impact of RaDaR(R) Assay for Molecular Residual Disease and Recurrence Monitoring at ASCO

May 29, 2023

NeoGenomics Reports First Quarter 2023 Results

May 7, 2023

NeoGenomics to Participate at the BofA Securities 2023 Healthcare Conference

May 2, 2023

NeoGenomics to Announce First Quarter 2023 Financial Results

April 16, 2023

NeoGenomics to Participate at the 22nd Annual Needham Virtual Healthcare Conference

April 10, 2023

NeoGenomics to Share Nine Abstracts at the American Association of Cancer Research (AACR) Annual Meeting 2023

April 5, 2023

NeoGenomics to Host Investor Day on April 4, 2023

March 26, 2023

Massive Bio and NeoGenomics Announce Collaboration to Accelerate Oncology Drug Discovery and Improve Patient Care

March 21, 2023

NeoGenomics Announces Commercial Availability of the RaDaR(R) Molecular Residual Disease Test

March 15, 2023

NeoGenomics Expands NGS Portfolio with Launch of Neo Comprehensive(TM) - Solid Tumor CGP and Neo Comprehensive(TM) - Myeloid Disorders CGP

March 12, 2023

NeoGenomics to Present at the 44th Annual Raymond James Institutional Investors Conference

February 27, 2023

NeoGenomics Reports Fourth Quarter and Full Year 2022 Results

February 22, 2023

RaDaR(R) Assay Demonstrates Clinical Potential for Helping Oncologists Determine Whether or Not Muscle-Invasive Bladder Cancer Patients Undergo Radical Surgery

February 5, 2023

NeoGenomics Schedules its Fourth Quarter and Full Year 2022 Earnings Release for February 23, 2023

February 5, 2023

Calls in 2023

Decks in 2023